Literature DB >> 10563377

Pharmacological and phytochemical studies of callus culture extracts from Alternanthera brasiliana.

A F Macedo1, N C Barbosa, M A Esquibel, M M Souza, V Cechinel-Filho.   

Abstract

This work describes the establishment of callus cultures of Alternanthera brasiliana, a Brazilian medicinal plant used to treat several ailments. In addition the two extracts, exhibiting best yields, were chemically analysed and evaluated as antinociceptive agents in two classical models of pain in mice: the writhing test and the formalin test. The results show that the highest biomass accumulation was observed in callus grown in media with higher concentrations of growth regulator of 2,4-D. Both extracts studied exhibited antinociceptive effects in mice, being more effective than the plant extracts. The pharmacological action seems to be related to the presence of steroids and/or terpenes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563377

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Comparative metabolomic responses to gibberellic acid and 6-benzylaminopurine in Cunila menthoides Benth. (Lamiaceae): a contribution to understand the metabolic pathways.

Authors:  Joana P S Oliveira; Maria Gabriela B Koblitz; Mariana S L Ferreira; L C Cameron; Andrea F Macedo
Journal:  Plant Cell Rep       Date:  2018-05-23       Impact factor: 4.570

2.  Influence of Alternanthera brasiliana (L.) Kuntze on Altered Antioxidant Enzyme Profile during Cutaneous Wound Healing in Immunocompromised Rats.

Authors:  Chandana Choudhury Barua; Shameem Ara Begum; Archana Talukdar; Jayanti Datta Roy; Bhaben Buragohain; Debesh Chandra Pathak; Dilip Kumar Sarma; Rumi Saikia Bora; Asheesh Gupta
Journal:  ISRN Pharmacol       Date:  2012-08-09

3.  Isolation of aurantiamides from gomphrena celosioides C. Mart.

Authors:  Omotayo Olutola Dosumu; Patricia Onocha; Olusegun Ekundayo; Muhammad Ali
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.